Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternatives

被引：2

作者：

Munoz-Garcia, Javier ^{[1
,2
]}

Heymann, Dominique ^{[1
,2
,3
]}

Giurgea, Irina ^{[4
]}

Legendre, Marie ^{[4
]}

Amselem, Serge ^{[4
]}

Castaneda, Beatriz ^{[5
]}

Lezot, Frederic ^{[4
]}

Vargas-Franco, Jorge William ^{[6
]}

机构：

[1] Inst Cancerol Ouest, F-44805 St Herblain, France

[2] Nantes Univ, CNRS, US2B, UMR 6286, F-44322 Nantes, France

[3] Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, England

[4] Sorbonne Univ, Hop Trousseau, AP HP, INSERM UMR933, F-75012 Paris, France

[5] Hop La Pitie Salpetriere, AP HP, Serv Orthope Dento Facial, Dept Odontol, F-75013 Paris, France

[6] Univ Antioquia, Fac Dent, Medellin, Colombia

来源：

BIOCHEMICAL PHARMACOLOGY | 2023年 / 213卷

关键词：

Osteogenesis Imperfecta; Pharmacological Treatment; Bisphosphonates; Antiresorptive Drugs; Anabolic Drugs; INTRAVENOUS PAMIDRONATE TREATMENT; GROWTH-HORMONE TREATMENT; BONE-MINERAL DENSITY; BISPHOSPHONATE TREATMENT; ALENDRONATE TREATMENT; STRONTIUM RANELATE; ZOLEDRONIC ACID; ADULT PATIENTS; FRACTURE RATE; ANTIRESORPTIVE THERAPIES;

D O I：

10.1016/j.bcp.2023.115584

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Osteogenesis imperfecta (OI) is a genetically heterogeneous connective tissue disorder characterized by bone fragility and different extra-skeletal manifestations. The severity of these manifestations makes it possible to classify OI into different subtypes based on the main clinical features.This review aims to outline and describe the current pharmacological alternatives for treating OI, grounded on clinical and preclinical reports, such as antiresorptive agents, anabolic agents, growth hormone, and anti-TGF beta antibody, among other less used agents. The different options and their pharmacokinetic and pharmacodynamic properties will be reviewed and discussed, focusing on the variability of their response and the molecular mechanisms involved to attain the main clinical goals, which include decreasing fracture incidence, improving pain, and promoting growth, mobility, and functional independence.

引用

页数：15

共 40 条

[31] Pharmacological treatment options for low Bone Mineral Density and secondary osteoporosis in Anorexia Nervosa: A systematic review of the literature
Robinson, Lauren
Aldridge, Victoria
Clark, Emma M.
Misra, Madhusmita
Micali, Nadia
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2017, 98 : 87 - 97
[32] The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options
Chandran, Manju
Lau, Tang Ching
Gagnon-Arpin, Isabelle
Dobrescu, Alexandru
Li, Wenshan
Leung, Man Yee Mallory
Patil, Narendra
Zhao, Zhongyun
ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
[33] Pharmacological Approaches to the Treatment of Dementia in Down Syndrome: A Systematic Review of Randomized Clinical Studies
de Oliveira, Laura Cavalcanti
de Paula Faria, Daniele
MOLECULES, 2022, 27 (10):
[34] Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly
Flaxer, Joseph M.
Heyer, Arianna
Francois, Dimitry
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (06) : 585 - 603
[35] Interventions for Improving Bone Mineral Density and Reducing Fracture Risk in Osteogenesis Imperfecta: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials
Sridharan, Kannan
Sivaramakrishnan, Gowri
CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (03): : 190 - 198
[36] Authors’ Reply to Alain Braillon’s Comment on “Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence”
Julia M. A. Sinclair
Sophia E. Chambers
David S. Baldwin
Drug Safety, 2016, 39 : 1153 - 1154
[37] Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
Li, Bob T.
Wong, Matthew H.
Pavlakis, Nick
JOURNAL OF CLINICAL MEDICINE, 2014, 3 (01) : 1 - 24
[38] Dentinogenesis imperfecta in a 6-year-old male neutered Labrador retriever: Case report with atypical clinical presentation and treatment review
Piekos, Karolina Maria
Freeman, Alix
Fleming, Kathryn
Bell, Cynthia
FRONTIERS IN VETERINARY SCIENCE, 2024, 11
[39] Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials
Lu, Junjie
Hu, Desheng
Zhang, Yan
Ma, Chen
Shen, Lin
Shuai, Bo
FRONTIERS IN ONCOLOGY, 2023, 13
[40] Comprehensive Review and Meta-Analysis of Psychological and Pharmacological Treatment for Intermittent Explosive Disorder: Insights From Both Case Studies and Randomized Controlled Trials
Liu, Fangqing
Yin, Xiaoshan
Jiang, Wenting
CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2025, 32 (01)

← 1 2 3 4 →